I. Hollin

发表

A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions

S. Kachnowski, Jin Wei, I. Hollin, 2011, Journal of telemedicine and telecare.

A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.

John F P Bridges, Ilene Hollin, J. Bridges, 2014, Clinical therapeutics.

Barriers to cross--institutional health information exchange: a literature review.

Ashley Edwards, Stan Kachnowski, Ilene Hollin, 2010, Journal of healthcare information management : JHIM.

Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer

I. Hollin, R. Dubois, Lisabeth Buelt, 2020, MDM policy & practice.

Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers

J. Coast, I. Hollin, K. Beusterien, 2019, The Patient - Patient-Centered Outcomes Research.

Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process.

J. Bridges, I. Hollin, H. Peay, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary fibrosis

J. Bridges, I. Hollin, S. Danoff, 2019, Patient preference and adherence.

Seeing is Engaging: Vlogs as a Tool for Patient Engagement

A. Wu, Joy L. Lee, I. Hollin, 2017, The Patient - Patient-Centered Outcomes Research.

Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment

J. Ball, I. Hollin, 2022, Exploratory research in clinical and social pharmacy.

Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic Review

Anne L R Schuster, I. Hollin, Norah L. Crossnohere, 2022, PharmacoEconomics.

Social and environmental determinants of health among children with long-term movement impairment

I. Hollin, A. Bagley, Carol A Tucker, 2022, Frontiers in Rehabilitation Sciences.

Screening parents during child evaluations: exploring parent and child psychopathology in the same clinic.

M. Rynn, I. Hollin, Charlotte Heleniak, 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

Proximal Femoral Focal Deficiency/Congenital Femoral Deficiency: Evaluation and Management.

I. Hollin, Corinna C Franklin, S. Nossov, 2022, The Journal of the American Academy of Orthopaedic Surgeons.

Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis

John F. P. Bridges, Ilene L. Hollin, Ellen Janssen, 2021, BMC Medical Informatics and Decision Making.

Caregiver Preferences for Emerging Duchenne Muscular Dystrophy Treatments: A Comparison of Best-Worst Scaling and Conjoint Analysis

John F P Bridges, J. Bridges, I. Hollin, 2015, The Patient - Patient-Centered Outcomes Research.

Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community.

S. Donaldson, I. Hollin, D. Borowitz, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Using Best–Worst Scaling to Investigate Preferences in Health Care

Kei Long Cheung, Silvia M A A Evers, Ellen M Janssen, 2016, PharmacoEconomics.

Care Management to Reduce Disparities and Control Hypertension in Primary Care: A Cost-effectiveness Analysis

J. Marsteller, W. Padula, L. Cooper, 2018, Medical care.

Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy

J. Bridges, I. Hollin, H. Peay, 2018, Quality of Life Research.

Patient‐centered benefit–risk assessment in duchenne muscular dystrophy

John F P Bridges, J. Bridges, S. Apkon, 2017, Muscle & nerve.

Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling

J. Bridges, I. Hollin, H. Peay, 2016, Journal of Genetic Counseling.

Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions.

J. Ball, I. Hollin, 2021, Research in social & administrative pharmacy : RSAP.

Perceptions of Live Donor Kidney Transplantation Using Segmentation Analysis and Perceptual Mapping to Understand Differences by Self-Reported Health Status in People on Dialysis

S. Bass, H. Gardiner, P. Kelly, 2022, Frontiers in Communication.

Innovation Spaces: Six Strategies to Inform Health Care

S. Kachnowski, I. Hollin, M. Griffin, 2012, The health care manager.

A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis

K. Robinson, I. Hollin, 2016, Applied Health Economics and Health Policy.

Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary ﬁ brosis Patient Adherence

I. Hollin, John F. P. Bridges, R. Bascom, 2019 .

A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.

J. Bridges, I. Hollin, H. Peay, 2014, Clinical therapeutics.

Role Preferences in Medical Decision Making: Relevance and Implications for Health Preference Research

I. Hollin, J. V. Van Til, Alison Pearce, 2023, The patient.

How will we know if it’s working? A multi-faceted approach to measuring usability of a specialty-specific electronic medical record

Margaret Griffin, Stan Kachnowski, Ilene Hollin, 2012, Health Informatics J..

The rise of best-worst scaling for prioritization: A transdisciplinary literature review

I. Hollin, Norah L. Crossnohere, Anne L. R. Schuster, 2024, Journal of Choice Modelling.

Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process.

J. Bridges, I. Hollin, H. Peay, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.